Clinical Trial Update: An Open-label Study of the Effects of Acetyl-L-Carnitine on Cardiovascular Outcomes in Friedreich's Ataxia [NA]

View source ↗

Summary

An open-label clinical trial is evaluating the effects of acetyl-L-carnitine on cardiovascular outcomes in Friedreich's Ataxia. The document lists the status as…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Friedreich Ataxia

Drugs mentioned

• Acetyl-L-carnitine (N-acetyl-L-carnitine)

Snippet

Sponsor: University of South Florida | Conditions: Friedreich's Ataxia | NA | Status: UNKNOWN